Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Julia Rawlings

Concepts (55)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Safety Management
2
2018
124
0.620
Why?
Patient Safety
2
2018
338
0.510
Why?
Pharmacy Service, Hospital
1
2018
81
0.500
Why?
Organizational Culture
1
2018
162
0.490
Why?
Remote Consultation
1
2022
66
0.180
Why?
Drug Overdose
1
2022
363
0.140
Why?
Pharmacy
1
2017
30
0.120
Why?
Pharmaceutical Services
1
2017
77
0.120
Why?
Benchmarking
1
2017
181
0.120
Why?
Opioid-Related Disorders
1
2022
582
0.110
Why?
Pharmacists
1
2017
240
0.110
Why?
Colchicine
1
2012
21
0.100
Why?
Gout Suppressants
1
2012
18
0.090
Why?
Gout
1
2012
35
0.090
Why?
Hematologic Diseases
1
2012
68
0.090
Why?
Chemical and Drug Induced Liver Injury
1
2012
138
0.080
Why?
Renal Insufficiency
1
2012
167
0.080
Why?
Delivery of Health Care
1
2017
946
0.080
Why?
Attitude of Health Personnel
1
2018
1174
0.080
Why?
Cross-Sectional Studies
2
2018
5761
0.070
Why?
Surveys and Questionnaires
2
2018
6004
0.070
Why?
Endrin
1
2022
13
0.050
Why?
Sumatriptan
1
1999
6
0.040
Why?
Health Maintenance Organizations
1
1999
103
0.040
Why?
Colorado
2
2022
4578
0.030
Why?
Pain
1
2022
776
0.030
Why?
Migraine Disorders
1
1999
109
0.030
Why?
Pharmacies
1
2017
42
0.030
Why?
Analgesics, Opioid
1
2022
1135
0.030
Why?
Practice Patterns, Physicians'
1
2022
1322
0.030
Why?
Counseling
1
2017
400
0.030
Why?
Humans
5
2022
143822
0.020
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
17
0.020
Why?
Cytochrome P-450 CYP3A
1
2012
93
0.020
Why?
Insurance, Health, Reimbursement
1
2012
93
0.020
Why?
Drug Interactions
1
2012
398
0.020
Why?
Communication
1
2017
960
0.020
Why?
Enzyme Inhibitors
1
2012
832
0.020
Why?
United States
2
2022
15602
0.020
Why?
Prevalence
1
2012
2819
0.010
Why?
Case-Control Studies
1
2012
3614
0.010
Why?
Electronic Health Records
1
2012
1170
0.010
Why?
Cohort Studies
1
2012
5862
0.010
Why?
Efficiency
1
1999
103
0.010
Why?
Health Services
1
1999
116
0.010
Why?
Statistics, Nonparametric
1
1999
431
0.010
Why?
Cost of Illness
1
1999
320
0.010
Why?
Young Adult
1
2012
13915
0.010
Why?
Middle Aged
2
2012
35631
0.010
Why?
Patient Satisfaction
1
1999
700
0.010
Why?
Adult
2
2012
40130
0.010
Why?
Aged
1
2012
25616
0.010
Why?
Male
2
2012
71570
0.000
Why?
Female
2
2012
77571
0.000
Why?
Quality of Life
1
1999
3142
0.000
Why?
Rawlings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)